BIO B — Bio-Rad Laboratories Share News
0.000.00%
Last trade - 00:00- $9.75bn
- $9.34bn
- $2.58bn
Bio-Rad Labs rises on upbeat Q4 profit
U.S. RESEARCH ROUNDUP-Nvidia, Albemarle, Dropbox
Refile: Bio Rad Labs rises after posting upbeat fourth-quarter profit
Bio Rad Laboratories Inc reports results for the quarter ended in December - Earnings Summary
Brief: Bio-Rad Reports Fourth-Quarter And Full-Year 2023 Financial Results
Brief: Bio-Rad Q4 Adjusted EPS USD 3.1 Vs. IBES Estimate USD 2.82
Brief: Bio Rad Laboratories Entered Into A Credit Agreement Dated As Of February 13, 2024
Bio Rad Laboratories Inc expected to post earnings of $2.82 a share - Earnings Preview
Activist investor Ubben shutting down Inclusive Capital-sources (updated)
U.S. STOCKS ON THE MOVE-Dana, ArcBest, Chart Industries
U.S. STOCKS ON THE MOVE-Hasbro, Target, Corteva
Bio-Rad Laboratories misses estimates, falls to over 4-year low
U.S. STOCKS ON THE MOVE-Hershey, Southwest Airlines, JPMorgan Chase
Diagnostic firm Bio-Rad falls on downbeat Q3 results
Bio Rad Laboratories Inc reports results for the quarter ended in September - Earnings Summary
Bio-Rad Labs falls on downbeat Q3 sales, cuts FY revenue growth forecast
Bio-Rad Labs cuts 2023 revenue growth forecast as biotechs cut spending
Brief: Bio-Rad Q3 Adjusted EPS USD 2.33 Vs. IBES Estimate USD 2.78
Bio Rad Laboratories Inc expected to post earnings of $2.78 a share - Earnings Preview